Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1978-05-11
1980-05-13
Rosen, Sam
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
424258, 424260, 424261, 424262, 424273R, A61K 31495, A61K 3147, A61K 3148
Patent
active
042028973
ABSTRACT:
Certain known imidazo[2,1-a]isoindoles and isoquinolines, e.g., 5-(p-chlorophenyl)-5-hydroxy-2,3-dihydro-5H-imidazo[2,1-a]isoindole (mazindol), have been found to be useful as inhibitors of prolactin secretion, and may be so utilized alone or as an agent which enhances the action of other chemical compounds having activity in inhibiting prolactin secretion.
REFERENCES:
patent: 3852303 (1974-12-01), Houlihan
Chem. Abst. 9th Col. Index, vol. 76-85 (1972-1976), pp. 19265cs, 19267cs and 19268cs.
Babington Ronald G.
Harrington F. Eugene
Honor Robert S.
Rosen Sam
Sandoz Inc.
Sharkin Gerald D.
LandOfFree
Prolactin secretion inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolactin secretion inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolactin secretion inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-929854